301 related articles for article (PubMed ID: 28085910)
1. Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients.
Arai N; Nakamizo T; Ihara H; Koide T; Nakamura A; Tabuse M; Miyazaki H
PLoS One; 2017; 12(1):e0169300. PubMed ID: 28085910
[TBL] [Abstract][Full Text] [Related]
2. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
[TBL] [Abstract][Full Text] [Related]
3. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
Song TJ; Kim J
PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
[TBL] [Abstract][Full Text] [Related]
4. Acid-suppressive medications and risk of pneumonia in acute stroke patients: A systematic review and meta-analysis.
Marchina S; Doros G; Modak J; Helenius J; Aycock DM; Kumar S
J Neurol Sci; 2019 May; 400():122-128. PubMed ID: 30927619
[TBL] [Abstract][Full Text] [Related]
5. Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia.
Herzig SJ; Doughty C; Lahoti S; Marchina S; Sanan N; Feng W; Kumar S
Ann Neurol; 2014 Nov; 76(5):712-8. PubMed ID: 25164323
[TBL] [Abstract][Full Text] [Related]
6. Acid-suppressive medication use and the risk for hospital-acquired pneumonia.
Herzig SJ; Howell MD; Ngo LH; Marcantonio ER
JAMA; 2009 May; 301(20):2120-8. PubMed ID: 19470989
[TBL] [Abstract][Full Text] [Related]
7. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
MacLaren R; Reynolds PM; Allen RR
JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.
McCaleb RV; Gandhi AS; Clark SM; Clemmons AB
Ann Pharmacother; 2016 Jul; 50(7):541-7. PubMed ID: 27091869
[TBL] [Abstract][Full Text] [Related]
9. Examination of selected clinical factors and medication use as risk factors for pneumonia during stroke rehabilitation: a case-control study.
Marciniak C; Korutz AW; Lin E; Roth E; Welty L; Lovell L
Am J Phys Med Rehabil; 2009 Jan; 88(1):30-8. PubMed ID: 19096289
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors versus histamine-2 receptor blockers for stress ulcer prophylaxis in patients with sepsis: a retrospective cohort study.
Huang M; Han M; Han W; Kuang L
J Int Med Res; 2021 Jun; 49(6):3000605211025130. PubMed ID: 34182815
[TBL] [Abstract][Full Text] [Related]
11. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
[TBL] [Abstract][Full Text] [Related]
12. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
[TBL] [Abstract][Full Text] [Related]
13. Pneumonia prevention in intubated patients given sucralfate versus proton-pump inhibitors and/or histamine II receptor blockers.
Grindlinger GA; Cairo SB; Duperre CB
J Surg Res; 2016 Dec; 206(2):398-404. PubMed ID: 27884335
[TBL] [Abstract][Full Text] [Related]
14. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
[TBL] [Abstract][Full Text] [Related]
15. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study.
Maret-Ouda J; Panula J; Santoni G; Xie S; Lagergren J
J Gastroenterol; 2023 Aug; 58(8):734-740. PubMed ID: 37314495
[TBL] [Abstract][Full Text] [Related]
17. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):792-802. PubMed ID: 20623507
[TBL] [Abstract][Full Text] [Related]
18. Risk of Stroke-Associated Pneumonia With Acid-Suppressive Drugs: A Population-Based Cohort Study.
Ho SW; Hsieh MJ; Yang SF; Yeh YT; Wang YH; Yeh CB
Medicine (Baltimore); 2015 Jul; 94(29):e1227. PubMed ID: 26200649
[TBL] [Abstract][Full Text] [Related]
19. Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study.
Bateman BT; Bykov K; Choudhry NK; Schneeweiss S; Gagne JJ; Polinski JM; Franklin JM; Doherty M; Fischer MA; Rassen JA
BMJ; 2013 Sep; 347():f5416. PubMed ID: 24052582
[TBL] [Abstract][Full Text] [Related]
20. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
Xie Y; Bowe B; Li T; Xian H; Balasubramanian S; Al-Aly Z
J Am Soc Nephrol; 2016 Oct; 27(10):3153-3163. PubMed ID: 27080976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]